Shares of LHC Group, Inc. (NASDAQ:LHCG) have earned a consensus recommendation of “Buy” from the thirteen analysts that are currently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $76.80.
LHCG has been the topic of several recent research reports. Zacks Investment Research downgraded shares of LHC Group from a “hold” rating to a “sell” rating in a research report on Tuesday, January 9th. BidaskClub upgraded shares of LHC Group from a “strong sell” rating to a “sell” rating in a research report on Wednesday, February 7th. Stephens set a $74.00 price target on shares of LHC Group and gave the stock a “buy” rating in a report on Friday, March 2nd. Jefferies Group restated a “buy” rating and set a $84.00 price target on shares of LHC Group in a report on Wednesday, April 4th. Finally, Craig Hallum raised their price target on shares of LHC Group from $70.00 to $80.00 and gave the stock a “buy” rating in a report on Wednesday, April 4th.
NASDAQ:LHCG opened at $70.56 on Wednesday. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.97 and a current ratio of 1.97. LHC Group has a one year low of $51.38 and a one year high of $76.14. The company has a market cap of $1,260.58, a P/E ratio of 29.16, a price-to-earnings-growth ratio of 1.11 and a beta of 0.70.
LHC Group (NASDAQ:LHCG) last posted its earnings results on Wednesday, February 28th. The health services provider reported $0.62 EPS for the quarter, hitting the consensus estimate of $0.62. LHC Group had a net margin of 4.67% and a return on equity of 9.18%. The business had revenue of $292.40 million for the quarter, compared to the consensus estimate of $280.82 million. During the same period last year, the company earned $0.58 EPS. The firm’s revenue was up 24.2% compared to the same quarter last year. analysts expect that LHC Group will post 3.5 earnings per share for the current fiscal year.
In other LHC Group news, COO Donald Dwayne Stelly sold 14,216 shares of the firm’s stock in a transaction that occurred on Tuesday, March 13th. The shares were sold at an average price of $64.00, for a total transaction of $909,824.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 14.80% of the stock is currently owned by company insiders.
Several large investors have recently added to or reduced their stakes in the company. Dalton Greiner Hartman Maher & Co. increased its stake in shares of LHC Group by 24.8% in the 4th quarter. Dalton Greiner Hartman Maher & Co. now owns 304,858 shares of the health services provider’s stock valued at $18,673,000 after acquiring an additional 60,563 shares in the last quarter. Wasatch Advisors Inc. increased its stake in shares of LHC Group by 17.2% in the 4th quarter. Wasatch Advisors Inc. now owns 254,381 shares of the health services provider’s stock valued at $15,581,000 after acquiring an additional 37,241 shares in the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp increased its stake in shares of LHC Group by 558.3% in the 4th quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 200,000 shares of the health services provider’s stock valued at $12,250,000 after acquiring an additional 169,620 shares in the last quarter. Renaissance Technologies LLC increased its stake in shares of LHC Group by 1,862.8% in the 4th quarter. Renaissance Technologies LLC now owns 184,500 shares of the health services provider’s stock valued at $11,301,000 after acquiring an additional 175,100 shares in the last quarter. Finally, Deutsche Bank AG increased its stake in shares of LHC Group by 371.5% in the 4th quarter. Deutsche Bank AG now owns 148,880 shares of the health services provider’s stock valued at $9,117,000 after acquiring an additional 117,301 shares in the last quarter. Institutional investors own 89.87% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “LHC Group, Inc. (LHCG) Receives $76.80 Average Price Target from Analysts” was originally published by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://www.thelincolnianonline.com/2018/04/21/lhc-group-inc-lhcg-receives-76-80-average-price-target-from-analysts.html.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.